SCHEMBL4772408

SCHEMBL4772408

Cn1cnc2c(=O)nc(Cc3cccc(F)c3F)n(-c3ccc(F)cc3)c21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 2/20 0.33
MAPK14 Q16539 2/20 0.33
LMNA P02545 2/20 0.33
TP53 P04637 1/20 0.33
MAPK1 P28482 1/20 0.33
REN P00797 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
HKDC1 Q2TB90 2/20 0.31
NPC1 O15118 1/20 0.31
CYP2C19 P33261 1/20 0.31
TSHR P16473 2/20 0.31
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
JAK2 O60674 1/20 0.31
JAK3 P52333 1/20 0.31
MPO P05164 1/20 0.31
KCNH2 Q12809 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
GPBAR1 Q8TDU6 1/20 0.31
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4505798 0.83 HKDC1 (0.39) TRPV4MAPK14LMNATP53MAPK1
SCHEMBL4777218 0.82 CYP2C19 (0.33) LMNASMN1; SMN2HKDC1NPC1CYP2C19
SCHEMBL4769786 0.78 LMNA (0.41) LMNATP53MAPK1L3MBTL1ALDH1A1
SCHEMBL4520110 0.76 SMN1; SMN2 (0.40) TRPV4LMNAMAPK1SMN1; SMN2HKDC1
SCHEMBL4777997 0.76 TSHR (0.39) LMNATP53CYP2C19TSHRKCNH2
SCHEMBL4767309 0.76 BRD9 (0.35) TP53MPO
SCHEMBL4776782 0.75 CDK1 (0.33) LMNASMN1; SMN2HKDC1NPC1CYP2C19
SCHEMBL4778102 0.75 MAPK1 (0.36) TP53MAPK1SMN1; SMN2HKDC1NPC1
SCHEMBL4525993 0.75 DRD1 (0.37) MAPK14LMNATP53NPC1TSHR
SCHEMBL4778022 0.75 P2RX7 (0.39) LMNATP53MAPK1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881988-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2008-01-30 EP disclosed
WO-2006122200-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2006-11-16 WO disclosed